Celltrion and Rani Therapeutics team up on oral monoclonal antibody treatment
Celltrion, one of Korea’s largest biopharma companies, will be Rani’s exclusive supplier of ustekinumab biosimilar, CT-P43, for its oral RT-111 RaniPill program.
Archives for January 11, 2023